BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Stellar Pharmaceuticals Inc. 

201- 82 Wellington Street South

London  Ontario  N6B 2K3  Canada
Phone: 519-434-1540 Fax: 519-434-4382


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Stellar Pharmaceuticals Inc. (SLX.V) Enters Into a Partnership With Pfizer Canada Inc. to Promote Gelfoam(R) in Canada 8/23/2012 8:00:35 AM    More...
Health Canada Approves Stellar Pharmaceuticals Inc. (SLX.V)'s CAMBIA(R) for the Treatment of Acute Migraine 3/16/2012 8:35:20 AM    More...
Apricus Biosciences (APRI), Stellar Pharmaceuticals Inc. (SLX.V) Sign MycoVa License Agreement in Canada 1/3/2012 7:48:00 AM    More...
Stellar Pharmaceuticals Inc. (SLX.V) Receives European Approval for NeoVisc(R) Single Dose 9/13/2011 7:12:44 AM    More...
Stellar Pharmaceuticals Inc. (SLX.V) and Watson Pharmaceuticals, Inc. (WPI) Terminate Uracyst(R) Supply and Licensing Agreements 4/13/2011 6:58:09 AM    More...
Stellar Pharmaceuticals Inc. (SLX.V) Announces Retirement of Peter Riehl as CEO, President and Director 1/18/2011 6:45:23 AM    More...
Stellar Pharmaceuticals Inc. (SLX.V) Annouces the Approval of Uracyst(R) by the KFDA in South Korea 1/6/2011 9:32:00 AM    More...
Stellar Pharmaceuticals Inc. (SLX.V) Provides Further Update on the Watson Pharmaceuticals, Inc. (WPI)'s Ur008 Pilot Study of Uracyst(R) 11/16/2010 9:30:39 AM    More...
Watson Pharmaceuticals, Inc. (WPI) Backs off from U.S. Plan for Stellar Pharmaceuticals Inc. (SLX.V)'s Uracyst Bladder Treatment After Study Does Not Meet Primary Endpoints 11/11/2010 6:58:02 AM    More...
Stellar Pharmaceuticals Inc. (SLX.V) Reports Third Quarter 2010 Financial Results 11/9/2010 9:17:50 AM    More...
12345678910...